(2025). Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review. Forum of Clinical Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Use of Histone Deacetylase Inhibitors (HDACis) in Pancreatic Ductal Adenocarcinoma (PDAC): A Narrative Review."
Forum of Clinical Oncology 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Use of Histone Deacetylase Inhibitors (HDACis) in Pancreatic Ductal Adenocarcinoma (PDAC): A Narrative Review."
Forum of Clinical Oncology, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.